About Felixvet
Felixvet was founded in 2014 and is based in Dublin, Ireland, within the veterinary pharmaceuticals sector. Generic and complex products are developed, manufactured, and marketed specifically for companion animals. The portfolio encompasses conventional generics, value-added generics, and complex generics, spanning multiple therapeutic areas and delivery formats. Bio-equivalent options are supplied to address requirements of veterinarians and pet owners. The management includes specialists in drug development, licensing, and sales.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Felix Pharmaceuticals Pvt. Ltd
- Jurisdiction Kolkata, West Bengal, India
-
Annual Revenue
$10.57 K (USD)-1.65as on Mar 31, 2022
-
Net Profit
$6.63 K (USD)351.01as on Mar 31, 2022
-
EBITDA
-$1.58 K (USD)75.07as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Felixvet
Unlock access to complete
Funding Insights of Felixvet
Investors in Felixvet
Felixvet has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Advent International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Felixvet
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Felixvet
Investment portfolio details for Felixvet
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Felixvet
Detailed financials for Felixvet
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Felixvet Comparisons
Peer comparison for Felixvet
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Felixvet
Detailed competitors of Felixvet
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Felixvet
Complete news archive for Felixvet
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Felixvet
Felixvet was founded in 2014 and raised its 1st funding round 11 years after it was founded.
Felixvet is headquartered in Dublin, Ireland.
Annual revenue of Felixvet is $10.57K as on Mar 31, 2022.
Felixvet was founded in 2014 and is based in Dublin, Ireland, within the veterinary pharmaceuticals sector. Generic and complex products are developed, manufactured, and marketed specifically for companion animals. The portfolio encompasses conventional generics, value-added generics, and complex generics, spanning multiple therapeutic areas and delivery formats. Bio-equivalent options are supplied to address requirements of veterinarians and pet owners. The management includes specialists in drug development, licensing, and sales.
Felixvet has 1 investor. Key investors include Advent International.